Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margret Einarsdottir

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Laeknabladid|February 5, 2019
[The association of musculoskeletal symptoms with teenage work in Iceland]Margret Einarsdottir
Laeknabladid|November 22, 2014
[Work injuries of 13-17-year-old Icelanders: causes and consequences]Margret Einarsdottir, Gudbjorg Linda Rafnsdottir, Jonina Einarsdottir
Lakartidningen|February 12, 2025
[Glucocorticoid-induced adrenal insufficiency]Marcus Imamovic, Per Dahlqvist, Oskar Ragnarsson, et al.
Lakartidningen|January 12, 2022
Margret Einarsdottir, Per Dahlqvist, Sophie Bensing, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancerElisabeth Rasmusson, Adalsteinn Gunnlaugsson, Elisabeth Kjellén, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Laeknabladid|February 5, 2019
[The association of musculoskeletal symptoms with teenage work in Iceland]Margret Einarsdottir
Laeknabladid|November 22, 2014
[Work injuries of 13-17-year-old Icelanders: causes and consequences]Margret Einarsdottir, Gudbjorg Linda Rafnsdottir, Jonina Einarsdottir
Lakartidningen|February 12, 2025
[Glucocorticoid-induced adrenal insufficiency]Marcus Imamovic, Per Dahlqvist, Oskar Ragnarsson, et al.
Lakartidningen|January 12, 2022
Margret Einarsdottir, Per Dahlqvist, Sophie Bensing, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancerElisabeth Rasmusson, Adalsteinn Gunnlaugsson, Elisabeth Kjellén, et al.
Pageof 1